2024 ICD-10-CM Diagnosis Code E21.0

Primary hyperparathyroidism

ICD-10-CM Code:
E21.0
ICD-10 Code for:
Primary hyperparathyroidism
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Endocrine, nutritional and metabolic diseases
    (E00–E89)
    • Disorders of other endocrine glands
      (E20-E35)
      • Hyperparathyroidism and other disorders of parathyroid gland
        (E21)

E21.0 is a billable diagnosis code used to specify a medical diagnosis of primary hyperparathyroidism. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Familial hyperparathyroidism
  • Familial isolated hyperparathyroidism
  • Hyperparathyroidism-jaw tumor syndrome
  • Neonatal hyperparathyroidism
  • Neonatal severe primary hyperparathyroidism
  • Nephropathy, deafness, hyperparathyroidism syndrome
  • Normocalcemic primary hyperparathyroidism
  • Osteitis fibrosa cystica
  • Parathyroid hyperplasia
  • Parathyroid hyperplasia
  • Primary hyperparathyroidism
  • Primary hyperparathyroidism
  • Primary water-clear cell hyperplasia

Clinical Classification

Clinical Information

  • Osteitis Fibrosa Cystica

    a fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to hyperparathyroidism.
  • Hyperparathyroidism

    a condition of abnormally elevated output of parathyroid hormone (or pth) triggering responses that increase blood calcium. it is characterized by hypercalcemia and bone resorption, eventually leading to bone diseases. primary hyperparathyroidism is caused by parathyroid hyperplasia or parathyroid neoplasms. secondary hyperparathyroidism is increased pth secretion in response to hypocalcemia, usually caused by chronic kidney diseases.
  • Neonatal Severe Primary Hyperparathyroidism

    an autosomal recessive form of kenny-caffey syndrome that is secondary to mutation(s) in the tcbe gene that encodes tubulin-specific chaperone e; it is characterized by the following: hypoparathyroidism with hypocalcemia, marked growth retardation, craniofacial anomalies, absent diploic space, cortical thickening and medullary stenosis of long bones, and small hands and feet.
  • Primary Hyperparathyroidism

    hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. it is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. it is associated with hypercalcemia and hypophosphatemia. signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Hyperplasia of parathyroid
  • Osteitis fibrosa cystica generalisata von Recklinghausen's disease of bone

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert E21.0 to ICD-9-CM

  • ICD-9-CM Code: 252.01 - Primary hyperparathyroid

Patient Education


Parathyroid Disorders

Most people have four pea-sized glands, called parathyroid glands, on the thyroid gland in the neck. Though their names are similar, the thyroid and parathyroid glands are completely different. The parathyroid glands make parathyroid hormone (PTH), which helps your body keep the right balance of calcium and phosphorous.

If your parathyroid glands make too much or too little hormone, it disrupts this balance. If they secrete extra PTH, you have hyperparathyroidism, and your blood calcium rises. In many cases, a benign tumor on a parathyroid gland makes it overactive. Or, the extra hormones can come from enlarged parathyroid glands. Very rarely, the cause is cancer.

If you do not have enough PTH, you have hypoparathyroidism. Your blood will have too little calcium and too much phosphorous. Causes include injury to the glands, endocrine disorders, or genetic conditions. Treatment is aimed at restoring the balance of calcium and phosphorous.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases


[Learn More in MedlinePlus]

Familial isolated hyperparathyroidism

Familial isolated hyperparathyroidism is an inherited condition characterized by overactivity of the parathyroid glands (hyperparathyroidism). The four parathyroid glands are located in the neck, and they release a hormone called parathyroid hormone that regulates the amount of calcium in the blood. In familial isolated hyperparathyroidism, one or more overactive parathyroid glands release excess parathyroid hormone, which causes the levels of calcium in the blood to rise (hypercalcemia). Parathyroid hormone stimulates the removal of calcium from bone and the absorption of calcium from the diet, and the mineral is then released into the bloodstream.

In people with familial isolated hyperparathyroidism, the production of excess parathyroid hormone is caused by tumors that involve the parathyroid glands. Typically only one of the four parathyroid glands is affected, but in some people, more than one gland develops a tumor. The tumors are usually noncancerous (benign), in which case they are called adenomas. Rarely, people with familial isolated hyperparathyroidism develop a cancerous tumor called parathyroid carcinoma. Because the production of excess parathyroid hormone is caused by abnormalities of the parathyroid glands, familial isolated hyperparathyroidism is considered a form of primary hyperparathyroidism.

Disruption of the normal calcium balance resulting from overactive parathyroid glands causes many of the common signs and symptoms of familial isolated hyperparathyroidism, such as kidney stones, nausea, vomiting, high blood pressure (hypertension), weakness, and fatigue. Because calcium is removed from bones to be released into the bloodstream, hyperparathyroidism often causes thinning of the bones (osteoporosis). The age at which familial isolated hyperparathyroidism is diagnosed varies from childhood to adulthood. Often, the first indication of the condition is elevated calcium levels identified through a routine blood test, even though the affected individual may not yet have signs or symptoms of hyperparathyroidism or hypercalcemia.


[Learn More in MedlinePlus]

Primary Hyperparathyroidism

Describes symptoms, causes, and treatment of primary hyperparathyroidism where one or more enlarged parathyroid gland secretes too much parathyroid hormone.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.